[go: up one dir, main page]

FR2533827B1 - - Google Patents

Info

Publication number
FR2533827B1
FR2533827B1 FR8216485A FR8216485A FR2533827B1 FR 2533827 B1 FR2533827 B1 FR 2533827B1 FR 8216485 A FR8216485 A FR 8216485A FR 8216485 A FR8216485 A FR 8216485A FR 2533827 B1 FR2533827 B1 FR 2533827B1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8216485A
Other languages
French (fr)
Other versions
FR2533827A1 (en
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bpifrance Financement SA
Original Assignee
Agence National de Valorisation de la Recherche ANVAR
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Agence National de Valorisation de la Recherche ANVAR filed Critical Agence National de Valorisation de la Recherche ANVAR
Priority to FR8216485A priority Critical patent/FR2533827A1/en
Publication of FR2533827A1 publication Critical patent/FR2533827A1/en
Application granted granted Critical
Publication of FR2533827B1 publication Critical patent/FR2533827B1/fr
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/04Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/14Peptides containing saccharide radicals; Derivatives thereof, e.g. bleomycin, phleomycin, muramylpeptides or vancomycin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/5555Muramyl dipeptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
FR8216485A 1982-09-30 1982-09-30 Composition possessing immunoregulatory properties, in particular of non-specific immunological adjuvants, based on muramyl peptide and an aluminium derivative Granted FR2533827A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR8216485A FR2533827A1 (en) 1982-09-30 1982-09-30 Composition possessing immunoregulatory properties, in particular of non-specific immunological adjuvants, based on muramyl peptide and an aluminium derivative

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8216485A FR2533827A1 (en) 1982-09-30 1982-09-30 Composition possessing immunoregulatory properties, in particular of non-specific immunological adjuvants, based on muramyl peptide and an aluminium derivative

Publications (2)

Publication Number Publication Date
FR2533827A1 FR2533827A1 (en) 1984-04-06
FR2533827B1 true FR2533827B1 (en) 1985-04-05

Family

ID=9277889

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8216485A Granted FR2533827A1 (en) 1982-09-30 1982-09-30 Composition possessing immunoregulatory properties, in particular of non-specific immunological adjuvants, based on muramyl peptide and an aluminium derivative

Country Status (1)

Country Link
FR (1) FR2533827A1 (en)

Cited By (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7790167B2 (en) 1997-11-10 2010-09-07 Cyt Immune Sciences, Inc. Methods and compositions for enhancing immune response and for the production of in vitro Mabs
US7951614B2 (en) 2003-12-02 2011-05-31 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
US7960145B2 (en) 2007-11-08 2011-06-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
USRE42524E1 (en) 2001-04-30 2011-07-05 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US8137989B2 (en) 1994-03-18 2012-03-20 Cytimmune Sciences, Inc. Method for delivering a cytokine using a colloidal metal

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS62162963A (en) * 1986-01-10 1987-07-18 Sadao Shiosaka Specific antibody of low molecular material prepared by using metallic colloid particle as carrier and preparation thereof
YU45382B (en) * 1986-11-19 1992-05-28 Pliva Sour Zagreb Process for preparing complex of n-acethyl-glucosis-aminyl-n-acethyl-muramoil-l-alanyl-d-izoglutaminyl-(l)-mezodiaminopimelyl-(d-amid)-(l)-al
FR2672495B1 (en) * 1991-02-08 1995-10-20 Vacsyn France Sa IMMUNOMODULATOR COMPOSITIONS, BASED ON PRODUCTS COMPRISING AT LEAST ONE PHOSPHATE OR SULFATE GROUP, AND A GEL OF AN ALUMINUM COMPOUND.
FR2692149B1 (en) * 1992-06-12 1995-06-09 Vacsyn France Sa ADJUVANT COMPOSITION OF HUMOR AND CELL-MEDIATED IMMUNITY WITHOUT RESPONSE TO SELF-ANTIGENIC DETERMINANTS.
US6274552B1 (en) 1993-03-18 2001-08-14 Cytimmune Sciences, Inc. Composition and method for delivery of biologically-active factors
FR2730936B1 (en) * 1994-12-21 1997-10-31 Vacsyn Sa VACCINE WITH INCREASED IMMUNOGENICITY
FR2730935A1 (en) * 1994-12-21 1996-08-30 Vacsyn Sa VACCINE WITH INCREASED IMMUNOGENICITY
WO1998046251A1 (en) * 1997-04-11 1998-10-22 Oleg Vitalievich Kaljuzhin Immunomodulator and pharmaceutical compositions with antitumor properties, and a food additive
RU2138268C1 (en) * 1997-09-22 1999-09-27 Мосин Владимир Александрович Agent suppressing proliferation and causing death of tumor cells and protecting normal cells
AU4251300A (en) 1999-05-07 2000-11-21 University Of Virginia Patent Foundation Biological production of stable glutamine, poly-glutamine derivatives in transgenic organisms and their use for therapeutic purposes

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1189340A (en) * 1967-09-13 1970-04-22 American Cyanamid Co Antigen-Adjuvant Composition
GB1218277A (en) * 1968-08-20 1971-01-06 Miles Lab Dry water-dispersible aluminium hydroxide gels
FR2288527A2 (en) * 1974-10-22 1976-05-21 Anvar Oil-free adjuvant compsns causing no hypersensitisation - contg N-acetyl-muramyl-L-alanyl-D-isoglutamine pref in aq soln
FR2343483A1 (en) * 1976-03-10 1977-10-07 Anvar Immunogical adjuvants for weak vaccine antigens - are (2)-acetamido-deoxy (D)-glucopyranosyl (D)-propionyl (L)-alanyl (D)-glutamic acid esters and (D)-isoglutamines
FR2369292A1 (en) * 1976-11-02 1978-05-26 Anvar ADJUSTING AGENTS IMMUNITY
FR2446292A1 (en) * 1979-01-12 1980-08-08 Anvar MURAMYL-PEPTIDES FIXED ON PEPTIDE POLYMERS AND MEDICAMENTS CONTAINING THEM

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8137989B2 (en) 1994-03-18 2012-03-20 Cytimmune Sciences, Inc. Method for delivering a cytokine using a colloidal metal
US7790167B2 (en) 1997-11-10 2010-09-07 Cyt Immune Sciences, Inc. Methods and compositions for enhancing immune response and for the production of in vitro Mabs
USRE42524E1 (en) 2001-04-30 2011-07-05 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US8785202B2 (en) 2001-04-30 2014-07-22 Cytimmune Sciences, Inc. Colloidal metal compositions and methods
US7951614B2 (en) 2003-12-02 2011-05-31 Cytimmune Sciences, Inc. Methods and compositions for the production of monoclonal antibodies
US7960145B2 (en) 2007-11-08 2011-06-14 Cytimmune Sciences, Inc. Compositions and methods for generating antibodies
US8486663B2 (en) 2007-11-08 2013-07-16 Cytlmmune Sciences, Inc. Compositions and methods for generating antibodies

Also Published As

Publication number Publication date
FR2533827A1 (en) 1984-04-06

Similar Documents

Publication Publication Date Title
DE3375706T (en)
FR2520504B3 (en)
DE3347853A1 (en)
FR2519260B3 (en)
DE3376194T2 (en)
FR2520233B1 (en)
FR2520946B1 (en)
DE3348339A1 (en)
FR2533827B1 (en)
FR2520171B1 (en)
FR2535462B1 (en)
FR2523743B1 (en)
FR2525022B1 (en)
FR2521165B1 (en)
FR2522587B1 (en)
FR2520133B1 (en)
FR2520516B1 (en)
FR2520545B1 (en)
FR2520204B1 (en)
FR2520168B1 (en)
FR2520063B3 (en)
FR2520416B1 (en)
FR2520783B1 (en)
FR2520582B1 (en)
FR2520267B1 (en)

Legal Events

Date Code Title Description
ST Notification of lapse